NoteSwift Expands Partnership in Allscripts Developer Program

Boston, MA, October 15, 2014 -- NoteSwift Inc. announced today the availability of NoteSwift™ for Allscripts TouchWorks® EHR. NoteSwift is the bridge between the EHR and Dragon Medical and interprets speech either as commands that a clinician can use to navigate the TouchWorks Note module, or as content to be inserted into the patient note. NoteSwift significantly reduces the time a provider spends creating a patient note – often by half – and virtually eliminates mouse clicks – one of the major pain points physicians state impedes EHR use. The provider can create a patient note that contains all relevant and billable data, quickly and easily, and experience increased satisfaction with TouchWorks EHR and Dragon Medical.

New SwiftNav™ technology within NoteSwift facilitates navigation through the patient note. No more clicking through multiple screens or on check boxes – simply say the name of the section of the note or item to be selected and NoteSwift automatically takes you there or selects the box. The need for keyboard and mouse is virtually unnecessary in most sections of the note as providers can dictate both structured and narrative text, and, due to the certified integration with TouchWorks via the Allscripts Developer Program – NoteSwift is able to discern which parts of the dictated speech will be automatically entered in specific fields.

NoteSwift provides the following benefits:

  •     Create a patient note in less than 5 clicks
  •     Reduce the amount of time it takes to complete a note, allowing providers to see more patients/day
  •     Enter both narrative text and structured data via medical speech recognition
  •     Enter ICD and CPT codes via speech to support Meaningful Use guidelines and reduce reimbursement denials

“Making EHRs easier to use while minimizing the time it takes to create patient notes is critical for the successful adoption of EHRs,” said NoteSwift’s President and CEO, Wayne Crandall. “With NoteSwift, we can often reduce mouse clicks by more than 90% which streamlines medical speech recognition.”

“The Allscripts Developer Program supports integration with multiple Allscripts products, including TouchWorks, Professional EHR, Practice Management and Sunrise Acute Care solutions”, said Stanley Crane, Chief Innovation Officer and General Manager, Open Business Unit, Allscripts. “We’re excited to see partners like NoteSwift integrate with multiple products through the Allscripts Developer Program to enable more of our clients to streamline their documentation and see more patients.”

NoteSwift allows the provider to utilize speech recognition in a more intuitive way without having to learn everything about the technology they are using. The provider can navigate within the note, speak the narrative as well as the structured data, and NoteSwift does all the heavy lifting. The note is completed at the point of care in minutes, with minimal clicking, and no third party is needed for transcription which helps save money.

For more information about NoteSwift, visit us on the Allscripts Application Store or email info(at)noteswift(dot)com for a custom quote and demo.

About NoteSwift

NoteSwift is dedicated to improving physician workflow with innovative technology solutions. The company was founded by Dr. Chris Russell, a software engineer-turned-physician who recognized that speech recognition was an unfulfilled technology in medicine with great promise. NoteSwift offers speech recognition enhancement solutions for both Allscripts TouchWorks and Professional EHRs.

NoteSwift and the NoteSwift logo are trademarks or registered trademarks of NoteSwift Corporation, Inc. in the United States of America and/or other countries. All other company names or product names may be the trademarks of their respective owners.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.